Related Experiment Video
Updated: Oct 29, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Downregulation of Long Noncoding RNA LINC00261 Attenuates Myocardial Infarction through the miR-522-3p/Trinucleotide
Chaoxin Jiang1, Qing Zhao2, Chenlong Wang3
1Department of Clinical Laboratory, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong 528200, China.
Background:
Myocardial infarction (MI) is cardiac tissue necrosis caused by acute and persistent ischemic hypoxia of the coronary arteries. This study is aimed at investigating the expression of long noncoding RNA (lncRNA) LINC00261 in MI and its effect on myocardial cells.
Methods:
qRT-PCR was performed to detect the expression levels of LINC00261, miR-522-3p, and TNRC6A in normal and MI cells. Western blotting analysis was performed to detect the expression of TNRC6A protein. Viability and apoptosis of myocardial cells after MI with the knockout of LINC00261 or TNRC6A were detected. The relationships among miR-522-3p, LINC00261, and TNRC6A in cardiomyocytes were evaluated using a double luciferase reporter gene assay. Hypoxic preconditioning in normal cells was used to construct a simulated MI environment to investigate the effect of LINC00261 on apoptosis of cardiac cells.
Results:
LINC00261 and TNRC6A were upregulated, while miR-522-3p was downregulated in coronary heart disease tissues with MI. Knockout of LINC00261 can increase the viability of cardiomyocytes and inhibit cell apoptosis. LINC00261 targets miR-522-3p in cardiomyocytes. In addition, miR-522-3p targets TNRC6A in cardiomyocytes. TNRC6A regulates cell viability and apoptosis of cardiomyocytes after MI, and TNRC6A-induced MI can be reversed by overexpression of miR-522-3p.
Conclusions:
LINC00261 downregulated miR-522-3p in cardiomyocytes after MI by directly targeting miR-522-3p. TNRC6A is the direct target of miR-522-3p. Our results indicated that LINC00261 might serve as a therapeutic target for the treatment of MI.
Insights
Long noncoding RNA LINC00261 exacerbates myocardial infarction (MI) by downregulating miR-522-3p, leading to increased TNRC6A expression and cardiomyocyte apoptosis. LINC00261 inhibition shows therapeutic potential for MI treatment.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Genetics
Background:
- Myocardial infarction (MI) involves cardiac tissue death due to prolonged coronary artery ischemia.
- Investigating the role of long noncoding RNA (lncRNA) LINC00261 in MI pathogenesis is crucial.
- Understanding the molecular mechanisms underlying MI can lead to novel therapeutic strategies.
Purpose of the Study:
- To investigate the expression of lncRNA LINC00261 in myocardial infarction (MI).
- To elucidate the regulatory network involving LINC00261, miR-522-3p, and TNRC6A in MI.
- To assess the therapeutic potential of targeting LINC00261 in MI treatment.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to measure LINC00261, miR-522-3p, and TNRC6A expression.
- Western blotting to detect TNRC6A protein levels.
- Cell viability and apoptosis assays in cardiomyocytes with manipulated LINC00261 and TNRC6A levels.
- Double luciferase reporter assays to confirm molecular interactions.
Main Results:
- LINC00261 and TNRC6A were upregulated, while miR-522-3p was downregulated in MI tissues.
- LINC00261 knockout enhanced cardiomyocyte viability and reduced apoptosis.
- LINC00261 directly targets miR-522-3p, which in turn targets TNRC6A, influencing cardiomyocyte apoptosis in MI.
Conclusions:
- LINC00261 downregulates miR-522-3p in MI cardiomyocytes via direct targeting.
- TNRC6A is a direct target of miR-522-3p, mediating MI-related effects.
- LINC00261 presents a potential therapeutic target for myocardial infarction treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Experimental RNAi
Types of RNA
RNA Performs Diverse...

